Macrophage migration inhibitory factor promotes resistance to glucocorticoid treatment in EAE

OBJECTIVE: Glucocorticoids (GCs) are used as standard treatment for acute attacks of multiple sclerosis (MS). However, GCs eventually lose efficacy and do not prevent disease progression. Macrophage migration inhibitory factor (MIF) is the only known proinflammatory cytokine induced by GCs that inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Niannian, Kovalovsky, Andra, Fingerle-Rowson, Günter, Guentzel, M. Neal, Forsthuber, Thomas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529283/
https://www.ncbi.nlm.nih.gov/pubmed/26280015
http://dx.doi.org/10.1212/NXI.0000000000000139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529283/
https://www.ncbi.nlm.nih.gov/pubmed/26280015
http://dx.doi.org/10.1212/NXI.0000000000000139

Ejemplares similares